| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c10df6e2d687fc46a483dba1aab8d4ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a19b898cbe64f657ac6b6e481440cbb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c47cc8a7767a2510ba088d80fad2f90f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 |
| filingDate |
2004-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ae308b8d2b4a75ebbf1c76b31a0786d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b180df6b3f4c099b0dbe4a2cb5bd56f2 |
| publicationDate |
2005-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005034999-A2 |
| titleOfInvention |
Composition comprising association complex of a pharmaceutical and a poloxamer |
| abstract |
The present invention provides a composition including an association complex of a pharmaceutical composition and one or more polyethylene-polypropylene glycol block copolymers (poloxamers). The pharmaceutical composition may include a member selected from the group consisting of (a) an association complex of an eprosartan composition including eprosartan or a pharmaceutically acceptable salt of eprosartan and (b) the non zwitterionic compound 2-(7-chloro-5-methyl-4-oxo-3-phenyl-4,5 dihydro-3H-pyridazino (4,5-b)indol-1-yl)-N,N-dimethylacetamide (NZ). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007027494-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101272767-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007027494-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-015715-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7683062-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7713548-B2 |
| priorityDate |
2003-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |